BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20590878)

  • 1. Variant Creutzfeldt-Jakob disease.
    Ironside JW
    Haemophilia; 2010 Jul; 16 Suppl 5():175-80. PubMed ID: 20590878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant Creutzfeldt-Jakob disease: an update.
    Ironside JW
    Folia Neuropathol; 2012; 50(1):50-6. PubMed ID: 22505363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products.
    Ironside JW; Head MW
    Haemophilia; 2004 Oct; 10 Suppl 4():64-9. PubMed ID: 15479374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
    Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
    Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease.
    Bishop MT; Diack AB; Ritchie DL; Ironside JW; Will RG; Manson JC
    Brain; 2013 Apr; 136(Pt 4):1139-45. PubMed ID: 23449776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
    Llewelyn CA; Hewitt PE; Knight RS; Amar K; Cousens S; Mackenzie J; Will RG
    Lancet; 2004 Feb; 363(9407):417-21. PubMed ID: 14962520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of safety: variant Creutzfeldt-Jakob disease in the United Kingdom.
    Ironside JW
    Semin Hematol; 2003 Jul; 40(3 Suppl 3):16-22. PubMed ID: 14690064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.
    Brandel JP; Peckeu L; Haïk S
    Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant CJD. 18 years of research and surveillance.
    Diack AB; Head MW; McCutcheon S; Boyle A; Knight R; Ironside JW; Manson JC; Will RG
    Prion; 2014; 8(4):286-95. PubMed ID: 25495404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies.
    Ironside JW
    Haemophilia; 2006 Mar; 12 Suppl 1():8-15; discussion 26-8. PubMed ID: 16445812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective neuropathological review of prion disease in UK haemophilic patients.
    Lee CA; Ironside JW; Bell JE; Giangrande P; Ludlam C; Esiri MM; McLaughlin JE
    Thromb Haemost; 1998 Dec; 80(6):909-11. PubMed ID: 9869159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion transmission of human prion diseases.
    Zou S; Fang CT; Schonberger LB
    Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk.
    Crowder LA; Schonberger LB; Dodd RY; Steele WR
    Transfusion; 2017 Aug; 57(8):1875-1878. PubMed ID: 28444687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
    Bonda DJ; Manjila S; Mehndiratta P; Khan F; Miller BR; Onwuzulike K; Puoti G; Cohen ML; Schonberger LB; Cali I
    Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
    Peden AH; Ritchie DL; Ironside JW
    Folia Neuropathol; 2005; 43(4):271-8. PubMed ID: 16416391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of transmission of Creutzfeldt-Jakob disease by transfusion of blood, plasma, and plasma derivatives.
    Vamvakas EC
    J Clin Apher; 1999; 14(3):135-43. PubMed ID: 10540369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders.
    Millar CM; Connor N; Dolan G; Lee CA; Makris M; Wilde J; Winter M; Ironside JW; Gill N; Hill FG
    Haemophilia; 2010 Mar; 16(2):305-15. PubMed ID: 20487442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia.
    Peden A; McCardle L; Head MW; Love S; Ward HJ; Cousens SN; Keeling DM; Millar CM; Hill FG; Ironside JW
    Haemophilia; 2010 Mar; 16(2):296-304. PubMed ID: 20070383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious and Sporadic Prion Diseases.
    Knight R
    Prog Mol Biol Transl Sci; 2017; 150():293-318. PubMed ID: 28838665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study.
    Urwin PJ; Mackenzie JM; Llewelyn CA; Will RG; Hewitt PE
    Vox Sang; 2016 May; 110(4):310-6. PubMed ID: 26709606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.